PDCD5 expression predicts a favorable outcome in patients with hepatocellular carcinoma
Authors:
- Ying ChengYCYing Cheng
- Hui HeHHHui He
- Hai-Yang LiuHLHai-Yang Liu
- Yong-Feng LiuYLYong-Feng Liu
- 26 June 2013
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 43 (3) , 821-830
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 32 references indexed in Scilit:
- Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritisBiomarkers, 2013
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemiaLeukemia Research, 2006
- Association of the PDCD5 Locus With Lung Cancer Risk and Prognosis in SmokersJournal of Clinical Oncology, 2006
- Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cellsApoptosis, 2006
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Human programmed cell death 5 protein has a helical-core and two dissociated structural regionsBiochemical and Biophysical Research Communications, 2004
- Soluble expression in Escherichia coli, purification and characterization of a human TF-1 cell apoptosis-related protein TFAR19Protein Expression and Purification, 2002
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- TFAR19,a Novel Apoptosis-Related Gene Cloned from Human Leukemia Cell Line TF-1, Could Enhance Apoptosis of Some Tumor Cells Induced by Growth Factor WithdrawalBiochemical and Biophysical Research Communications, 1999